case_images: PMC11746010_01
case_images: Variations in CT imaging throughout the patient's treatment regimen. (A) The initial CT scan upon admission, revealing the presence of bilateral pleural effusions and a pericardial effusion. Four weeks post-admission, (B) a CT scan that exhibits an augmentation in pleural effusions from baseline, along with the presence of a visible pericardial drainage catheter. (C) A CT scan conducted 3 days following bevacizumab administration, demonstrating a notable decrease in pleural effusions. One week subsequent to the completion of bevacizumab therapy, (D) a CT scan indicating the full resolution of pleural effusions.
case_images: fmed-11-1483064-g0001.jpg
case_images: PMC11746010_01_fmed-11-1483064-g0001.jpg
case_images: F1
case_images: COVID-19 pandemic, the patient had not received the COVID-19 vaccine or any other vaccinations. Chest (Figure 1) and abdominal CT scans demonstrated bilateral pleural effusion, ascites, and pericardial effusion.
case_images: The patient's complete treatment course, including variations in body weight and plasma albumin concentrations throughout the therapeutic process.
case_images: fmed-11-1483064-g0002.jpg
case_images: PMC11746010_01_fmed-11-1483064-g0002.jpg
case_images: F2
case_images: The plasma albumin concentration escalated to 27.5 g/L (Figure 2).